Autonomous Medical Devices Incorporated (AMDI) has received a U.S. National Institutes of Health (NIH) RADx Tech award of up to $5.2 million to finalize its rapid point-of-care (POC) viral testing system.
The funding, awarded through the NIH’s National Institute of Biomedical Imaging and Bioengineering, will be used to complete the development of AMDI’s Fast PCR System, a reverse transcription-polymerase chain reaction POC system, and the Fast PCR system’s first test panel, designed to detect influenza A and B, RSV, and SARS-CoV-2.
The Fast PCR System is designed to detect up to 32 targets per sample in less than 10 minutes.
"The core of our system is the Hyperbaric Heating (HBH) sample prep technology combined with our ultrafast PCR chemistry. The HBH technology removes the time constraints and costs associated with traditional sample prep," Regis Peytavi, chief technology officer of AMDI, said in a statement. "Combining HBH with our ultrafast thermal cycling allows us to stay under 10 minutes regardless of the number of targets we put on the test disc."
AMDI was awarded $1.2 million in phase I funding from the RadX Tech program to develop the Fast PCR System in April 2023.
